XBIO: Xenetic Biosciences Inc. Stocks News on October 23, 2025

XBIO

MT Newswires

13 days ago

Xenetic Biosciences Prices $4.5 Million Stock Offering; Shares Fall

Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock

XBIO

ACCESS Newswire

13 days ago

Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock

XBIO

MT Newswires

15 days ago

Top Premarket Gainers

Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

XBIO

ACCESS Newswire

5 months ago

Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

XBIO

Associated Press Finance

5 months ago

Xenetic Biosciences: Q1 Earnings Snapshot

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment

XBIO

ACCESS Newswire

6 months ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment

$Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma$

XBIO

ACCESS Newswire

7 months ago

Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma

Xenetic Biosciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

XBIO

Simply Wall St.

7 months ago

Xenetic Biosciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results

XBIO

ACCESS Newswire

7 months ago

Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses

XBIO

ACCESS Newswire

7 months ago

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses

Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting

XBIO

ACCESS Newswire

8 months ago

Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting

XBIO

ACCESSWIRE

10 months ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment

Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform

XBIO

ACCESSWIRE

10 months ago

Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform

Xenetic Biosciences, Inc. Enters into Clinical Trial Services Agreement with PeriNess Ltd. to Accelerate Development of DNase I Oncology Program

XBIO

ACCESSWIRE

a year ago

Xenetic Biosciences, Inc. Enters into Clinical Trial Services Agreement with PeriNess Ltd. to Accelerate Development of DNase I Oncology Program

XBIO

ACCESSWIRE

a year ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis

XBIO

ACCESSWIRE

a year ago

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis

Xenetic Biosciences Third Quarter 2024 Earnings: Misses Expectations

XBIO

Simply Wall St.

a year ago

Xenetic Biosciences Third Quarter 2024 Earnings: Misses Expectations

Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results

XBIO

ACCESSWIRE

a year ago

Xenetic Biosciences, Inc. Reports Third Quarter 2024 Financial Results

XBIO

Associated Press Finance

a year ago

Xenetic Biosciences: Q3 Earnings Snapshot

Xenetic Biosciences, Inc. Presents Positive Data Demonstrating DNase I Significantly Improves Efficacy of Anti-CTLA-4 Immune Checkpoint Blockade in Preclinical Colorectal Carcinoma Models

XBIO

ACCESSWIRE

a year ago

Xenetic Biosciences, Inc. Presents Positive Data Demonstrating DNase I Significantly Improves Efficacy of Anti-CTLA-4 Immune Checkpoint Blockade in Preclinical Colorectal Carcinoma Models

Xenetic Biosciences, Inc. Extends Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform

XBIO

ACCESSWIRE

a year ago

Xenetic Biosciences, Inc. Extends Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform

Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024

XBIO

ACCESSWIRE

a year ago

Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024

Xenetic Biosciences, Inc. Enters into Materials Transfer Agreement with Tokyo Medical University for the Advancement of Its DNase-Based Oncology Platform

XBIO

ACCESSWIRE

a year ago

Xenetic Biosciences, Inc. Enters into Materials Transfer Agreement with Tokyo Medical University for the Advancement of Its DNase-Based Oncology Platform

Xenetic Biosciences, Inc. Presents at the H.C. Wainwright 26th Annual Global Investment Conference

XBIO

ACCESSWIRE

a year ago

Xenetic Biosciences, Inc. Presents at the H.C. Wainwright 26th Annual Global Investment Conference

Xenetic Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

XBIO

ACCESSWIRE

a year ago

Xenetic Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

XBIO

Zacks

a year ago

Xenetic Biosciences (XBIO) Reports Q2 Loss, Tops Revenue Estimates

XBIO

Associated Press Finance

a year ago

Xenetic Biosciences: Q2 Earnings Snapshot

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

XBIO

GOBankingRates

a year ago

5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers

Bumrah delivers as India beat Pakistan in low-scoring thriller

XBIO

AFP

a year ago

Bumrah delivers as India beat Pakistan in low-scoring thriller

Italy beat Bosnia in final Euros warm-up

XBIO

AFP

a year ago

Italy beat Bosnia in final Euros warm-up

Macron Calls French Legislative Election After Far-Right Surge

XBIO

Bloomberg

a year ago

Macron Calls French Legislative Election After Far-Right Surge

Trump loyalists proud to support 'felon' at Las Vegas rally

XBIO

AFP

a year ago

Trump loyalists proud to support 'felon' at Las Vegas rally

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

XBIO

Business Insider

a year ago

US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia

XBIO

Insider Monkey

a year ago

The Best Woody Perfume For Women

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

XBIO

Reuters

a year ago

Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase

XBIO

Journal-News, Hamilton, Ohio

a year ago

Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

XBIO

TechCrunch

a year ago

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now

XBIO

Motley Fool

a year ago

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now

Italian energy company targets Britain for fleet of 20 mini-nukes

XBIO

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

XBIO

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Saudis Said to Hand About 60% of Aramco Offer to Foreigners

XBIO

Bloomberg

a year ago

Saudis Said to Hand About 60% of Aramco Offer to Foreigners

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

XBIO

Simply Wall St.

a year ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

XBIO

Simply Wall St.

a year ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

XBIO

Business Wire

a year ago

Net Asset Value(s)

Europe Antibody Drug Conjugates Market Forecast to 2030: Increasing Investments to Develop ADCs Fuels the European Antibody Drug Conjugates Market

XBIO

GlobeNewswire

a year ago

Europe Antibody Drug Conjugates Market Forecast to 2030: Increasing Investments to Develop ADCs Fuels the European Antibody Drug Conjugates Market

Kenya Ecommerce Market Databook 2024-2028, Featuring Avechi, Jiji, Jumia, Kilimall, MyDawa, Bolt Food, Jumia Food, LetaFood, Yum Deliveries, Hava Net, Little Cab, Maramoja and Transport Wasili

XBIO

GlobeNewswire

a year ago

Kenya Ecommerce Market Databook 2024-2028, Featuring Avechi, Jiji, Jumia, Kilimall, MyDawa, Bolt Food, Jumia Food, LetaFood, Yum Deliveries, Hava Net, Little Cab, Maramoja and Transport Wasili

Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than

XBIO

PR Newswire

a year ago

Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than

UK's Sunak apologises for leaving D-Day ceremony early

XBIO

AFP

a year ago

UK's Sunak apologises for leaving D-Day ceremony early

3 Major Product Releases at 3Shape Discover Event

XBIO

PR Newswire

a year ago

3 Major Product Releases at 3Shape Discover Event

Fiber Optic Sensors Global Market Forecast & Analysis 2023-2033: Global Fiber Optic Sensors Market to Reach $605.4 Million by 2032 with a CAGR of 6.2%

XBIO

GlobeNewswire

a year ago

Fiber Optic Sensors Global Market Forecast & Analysis 2023-2033: Global Fiber Optic Sensors Market to Reach $605.4 Million by 2032 with a CAGR of 6.2%

Millions of Chinese students start exams in biggest 'gaokao' ever

XBIO

AFP

a year ago

Millions of Chinese students start exams in biggest 'gaokao' ever

Xenetic Biosciences, Inc. Announces Executive Leadership Transition

XBIO

ACCESSWIRE

a year ago

Xenetic Biosciences, Inc. Announces Executive Leadership Transition

Xenetic Biosciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

XBIO

Simply Wall St.

a year ago

Xenetic Biosciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

XBIO

ACCESSWIRE

a year ago

Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

XBIO

Zacks

a year ago

Xenetic Biosciences (XBIO) Reports Q1 Loss, Misses Revenue Estimates

XBIO

Associated Press Finance

a year ago

Xenetic Biosciences: Q1 Earnings Snapshot

Xenetic Biosciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

XBIO

Simply Wall St.

2 years ago

Xenetic Biosciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results

XBIO

ACCESSWIRE

2 years ago

Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results

NORTH EUROPEAN OIL ROYALTY TRUST ANNOUNCES THE DISTRIBUTION FOR THE FIRST QUARTER OF FISCAL 2024

XBIO

PR Newswire

2 years ago

NORTH EUROPEAN OIL ROYALTY TRUST ANNOUNCES THE DISTRIBUTION FOR THE FIRST QUARTER OF FISCAL 2024

Webuy Receives Nasdaq Notification Regarding Minimum Bid Requirements

XBIO

GlobeNewswire

2 years ago

Webuy Receives Nasdaq Notification Regarding Minimum Bid Requirements

XBIO

Associated Press Finance

2 years ago

Sierra Bancorp: Q4 Earnings Snapshot

Sierra Bancorp Reports Strategic Securities Transaction as Well as Fourth Quarter and Year End 2023 Results

XBIO

Business Wire

2 years ago

Sierra Bancorp Reports Strategic Securities Transaction as Well as Fourth Quarter and Year End 2023 Results

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

XBIO

GlobeNewswire

2 years ago

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress

XBIO

GlobeNewswire

2 years ago

Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress

Draganfly Selected For Innovative End-To-End Electric Mobility Platform In UAE

XBIO

GlobeNewswire

2 years ago

Draganfly Selected For Innovative End-To-End Electric Mobility Platform In UAE

David Perry Bought 8.6% More Shares In Better Therapeutics

XBIO

Simply Wall St.

2 years ago

David Perry Bought 8.6% More Shares In Better Therapeutics

Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform

XBIO

ACCESSWIRE

2 years ago

Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform

Senior Executives of Indonesia Energy Take on New Roles and New Board Member Added

XBIO

GlobeNewswire

2 years ago

Senior Executives of Indonesia Energy Take on New Roles and New Board Member Added

Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women

XBIO

PR Newswire

2 years ago

Movano Health and ams OSRAM Collaborate to Deliver Accurate Lifestyle Monitoring Solutions for Women

Celularity Confirms Commercialization Agreement with BioCellgraft for the Manufacture and Distribution of Advanced Biomaterial Products for Use in Oral Healthcare

XBIO

GlobeNewswire

2 years ago

Celularity Confirms Commercialization Agreement with BioCellgraft for the Manufacture and Distribution of Advanced Biomaterial Products for Use in Oral Healthcare

5E Advanced Materials Commences Mining Operations at 5E Boron Americas Complex

XBIO

GlobeNewswire

2 years ago

5E Advanced Materials Commences Mining Operations at 5E Boron Americas Complex

Inspira Announces $3.88 Million Registered Direct Offering

XBIO

PR Newswire

2 years ago

Inspira Announces $3.88 Million Registered Direct Offering

XBIO

Insider Monkey

2 years ago

11 Popular Penny Stocks on Robinhood

Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024”

XBIO

GlobeNewswire

2 years ago

Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024”

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab in Multiple Sclerosis

XBIO

GlobeNewswire

2 years ago

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab in Multiple Sclerosis

Gulf Island Fabrication (NASDAQ:GIFI) shareholders have endured a 46% loss from investing in the stock five years ago

XBIO

Simply Wall St.

2 years ago

Gulf Island Fabrication (NASDAQ:GIFI) shareholders have endured a 46% loss from investing in the stock five years ago

Akari Therapeutics to Present at Biotech Showcase 2024

XBIO

GlobeNewswire

2 years ago

Akari Therapeutics to Present at Biotech Showcase 2024

XBIO

PR Newswire

2 years ago

CHECK- CAP BOARD MEMBER'S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL

CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES

XBIO

CNW Group

2 years ago

CITING THE MANY FDA ADVERSE EFFECTS TO KEYSTONE DENTAL - CHECK-CAP FOUNDER STRONGLY RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER ALSO RECOMMENDS VOTING FOR THE SYMETRYX BOARD NOMINEES

XBIO

GuruFocus.com

2 years ago

Johnson Outdoors Inc (JOUT) Faces Headwinds: Fiscal 2023 Earnings Decline Amid Market Challenges

Gulf Island Announces Share Repurchase Program

XBIO

GlobeNewswire

2 years ago

Gulf Island Announces Share Repurchase Program

Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors

XBIO

GlobeNewswire

2 years ago

Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directors

XBIO

Zacks

2 years ago

The Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie

XBIO

Simply Wall St.

2 years ago

Most Shareholders Will Probably Agree With Xenetic Biosciences, Inc.'s (NASDAQ:XBIO) CEO Compensation

Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study

XBIO

ACCESSWIRE

2 years ago

Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study

Hanryu Holdings Reports Third Quarter and First Nine Month 2023 Financial Results

XBIO

ACCESSWIRE

2 years ago

Hanryu Holdings Reports Third Quarter and First Nine Month 2023 Financial Results

Is Vivani Medical (NASDAQ:VANI) In A Good Position To Invest In Growth?

XBIO

Simply Wall St.

2 years ago

Is Vivani Medical (NASDAQ:VANI) In A Good Position To Invest In Growth?

Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

XBIO

GlobeNewswire

2 years ago

Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

XBIO

GlobeNewswire

2 years ago

Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results

KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update

XBIO

GlobeNewswire

2 years ago

KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Need To Know: Analysts Just Made A Substantial Cut To Their Airgain, Inc. (NASDAQ:AIRG) Estimates

XBIO

Simply Wall St.

2 years ago

Need To Know: Analysts Just Made A Substantial Cut To Their Airgain, Inc. (NASDAQ:AIRG) Estimates

XBIO

Associated Press Finance

2 years ago

Xenetic Biosciences: Q3 Earnings Snapshot

Xenetic Biosciences, Inc. Reports Third Quarter 2023 Financial Results

XBIO

ACCESSWIRE

2 years ago

Xenetic Biosciences, Inc. Reports Third Quarter 2023 Financial Results

Strong Global Entertainment Reports Third Quarter 2023 Operating Results

XBIO

GlobeNewswire

2 years ago

Strong Global Entertainment Reports Third Quarter 2023 Operating Results

Dyadic International, Inc. (NASDAQ:DYAI) Q3 2023 Earnings Call Transcript

XBIO

Insider Monkey

2 years ago

Dyadic International, Inc. (NASDAQ:DYAI) Q3 2023 Earnings Call Transcript

XBIO

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Assertio Holdings Inc Earnings Call

Oncocyte Reports Third Quarter 2023 Financial Results

XBIO

GlobeNewswire

2 years ago

Oncocyte Reports Third Quarter 2023 Financial Results

Adams Resources & Energy Inc (AE) Reports Mixed Q3 Results Amidst Market Challenges

XBIO

GuruFocus.com

2 years ago

Adams Resources & Energy Inc (AE) Reports Mixed Q3 Results Amidst Market Challenges

XBIO

ACCESSWIRE

2 years ago

North Shore Uranium Ltd. (Formerly Clover Leaf Capital Corp.) Announces Closing Of Qualifying Transaction

Galera Announces Receipt of Type A Meeting Minutes and Strategic Update

XBIO

GlobeNewswire

2 years ago

Latest Xenetic Biosciences Inc. (XBIO) News on October 23, 2025

Share on Social Networks: